Business Description
YD Bio Ltd
ISIN : KYG983011076
Total Employee Number:
15Description
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 858.29 | |||||
Equity-to-Asset | -0.21 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 3.13 | |||||
Beneish M-Score | -1.78 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 56.19 | |||||
9-Day RSI | 46.85 | |||||
14-Day RSI | 41.93 | |||||
3-1 Month Momentum % | -37.62 | |||||
6-1 Month Momentum % | -70.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.88 | |||||
Quick Ratio | 4.74 | |||||
Cash Ratio | 3.65 | |||||
Days Inventory | 813.61 | |||||
Days Sales Outstanding | 72.35 | |||||
Days Payable | 186.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 27.97 | |||||
Operating Margin % | -882.41 | |||||
Net Margin % | -1392.13 | |||||
EBITDA Margin % | -1392.46 | |||||
FCF Margin % | -1346.23 | |||||
OCF Margin % | -1105.03 | |||||
ROE % | -282.62 | |||||
ROA % | -94.14 | |||||
ROIC % | -110.31 | |||||
ROC (Joel Greenblatt) % | -1449.94 | |||||
ROCE % | -104.68 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 283.76 | |||||
EV-to-EBIT | -18.62 | |||||
EV-to-EBITDA | -18.62 | |||||
EV-to-Revenue | 259.27 | |||||
EV-to-FCF | -19.26 | |||||
Earnings Yield (Greenblatt) % | -5.37 | |||||
FCF Yield % | -5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:YDES
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
YD Bio Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.597 | ||
| EPS (TTM) ($) | -0.117 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 41.93 | ||
| 14-Day ATR ($) | 0.425848 | ||
| 20-Day SMA ($) | 2.323 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 1.7 - 25 | ||
| Shares Outstanding (Mil) | 70.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
YD Bio Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
YD Bio Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-30 | In 137 days | ||
| Second quarter earnings results for 2026 | 2026-08-31 | In 46 days | ||
| First quarter earnings results for 2026 | 2026-07-17 | In 1 day | ||
| General meeting for 2026 | 2026-07-15 | 2.12 (-0.47%) | ||
| Annual report for 2025 | 2026-04-30 | 5.19 (-0.20%) | ||
| Fourth quarter earnings results for 2025 | 2026-04-30 | 5.19 (-0.20%) |
Show
Entries
YD Bio Ltd Frequently Asked Questions
What is YD Bio Ltd(YDES)'s stock price today?
The current price of YDES is $2.27. The 52 week high of YDES is $25.00 and 52 week low is $1.70.
When is next earnings date of YD Bio Ltd(YDES)?
The next earnings date of YD Bio Ltd(YDES) is 2026-07-17 Est..
Does YD Bio Ltd(YDES) pay dividends? If so, how much?
YD Bio Ltd(YDES) does not pay dividend.
Guru Commentaries on NAS:YDES
No articles.
Press Release
| Subject | Date | ||
|---|---|---|---|
| YD Bio Limited Announces Closing of Business Combination and Listing on the Nasdaq Global Market | 2025-08-29 |
Articles on YD Bio Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers